Clinical trial
TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment
NCT00164463 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00164463 |
|---|---|
| Title | TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment |
| Official title | TBTC Study 27/28 PK: Pharmacokinetic Issues in the Use of Moxifloxacin for Treatment of Tuberculosis |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | US Department of Veterans Affairs U.S. Fed Bayer Industry National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Drug |
| Interventions | Moxifloxacin, Isoniazid |
| Enrollment | 72 |
| Start date | Jul 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Sep 14, 2005 |
| Last update posted | Jun 8, 2011 |
| Countries | Canada, Uganda, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: